Haas Jason - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 12, 2024, Haas Jason's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Officer (Chief Financial Officer), and currently has 124,552 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRS insiders.
Data Source: SEC.
Haas Jason - Insider Non-Derivative Transactions of SYRS Common Stock
Haas Jason - Insider Non-Derivative Transactions at SYRS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 13, 2024 | P -- (Common Stock) | 45344 | 1.68 | 124552 |
| Sep 12, 2024 | P -- (Common Stock) | 19293 | 1.58 | 79208 |
| Sep 11, 2024 | P -- (Common Stock) | 35363 | 1.55 | 59915 |
| Apr 2, 2024 | F -- (Common Stock) | 4732 | 5.12 | 24552 |
| Apr 1, 2024 | M -- (Common Stock) | 2000 | 0 | 15951 |
| Apr 1, 2024 | M -- (Common Stock) | 13333 | 0 | 29284 |
| Nov 2, 2023 | F -- (Common Stock) | 6301 | 2.22 | 13951 |
| Nov 1, 2023 | M -- (Common Stock) | 18875 | 0 | 20252 |
| Apr 4, 2023 | F -- (Common Stock) | 623 | 2.58 | 1377 |
| Apr 1, 2023 | M -- (Common Stock) | 2000 | 0 | 2000 |